Catheter ablation restores decreased plasma miR-409-3p and miR-432 in atrial fibrillation patients

Europace

Volumn 18, Issue 1, 2015, Pages 92-99

  Liu, Tian ^a   Zhong, Shilong ^a   Rao, Fang ^a   Xue, Yumei ^a   Qi, Zhoucuo ^a   Wu, Shulin ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Atrial fibrillation; Catheter ablation; Differential expression; MiRNA; Plasma

Indexed keywords

MICRORNA; MICRORNA 152; MICRORNA 16 2; MICRORNA 328; MICRORNA 338 5P; MICRORNA 374A; MICRORNA 409 3P; MICRORNA 432; MICRORNA 454; MICRORNA 4732 3P; MICRORNA 486 5P; MICRORNA 487B; MICRORNA 493; MICRORNA 664; MICRORNA 766; MICRORNA 874; MICRORNA 9; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN409 MICRORNA, HUMAN; MIRN432 MICRORNA, HUMAN;

ADULT; ARTICLE; ATRIAL FIBRILLATION; BLOOD LEVEL; CARDIOVASCULAR DISEASE ASSESSMENT; CATHETER ABLATION; CHA2DS2 VASC SCORE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAN CHINESE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA SEQUENCE; BLOOD; DOWN REGULATION; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ATRIAL FIBRILLATION; BIOMARKERS; CATHETER ABLATION; DOWN-REGULATION; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84962030814     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu366     Document Type: Article

References (26)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155: 469-73
2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-5
3. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: 480-6
4. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012; 14: 528-606
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97
6. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-31
7. Qin S, Zhang C. MicroRNAs in vascular disease. J Cardiovasc Pharmacol 2011; 57: 8-12
8. Bhaskaran M, Mohan M. MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol 2013; 51: 759-74
9. Creemers EE, Tijsen AJ, Pinto YM Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 2012 110 483-95
10. Tijsen AJ, Pinto YM, Creemers EE. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol 2012; 303: H1085-95
11. Shi KH, Tao H, Yang JJ, WuJX, Xu SS, Zhan HY. Role of microRNAs in atrial fibrillation: new insights and perspectives. Cell Signal 2013; 25: 2079-84
12. Luo X, Zhang H, Xiao J, Wang Z. Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications. Cell Physiol Biochem 2010; 25: 571-86
13. Xiao J, Liang D, Zhang Y, Liu Y, ZhangH, Liu Y, et al. MicroRNA expression signature in atrial fibrillation with mitral stenosis. Physiol Genomics 2011; 43: 655-64
14. Nishi H, Sakaguchi T, Miyagawa S, Yoshikawa Y, Fukushima S, Saito S, et al. Impact of microRNA expression in human atrial tissue in patients with atrial fibrillation undergoing cardiac surgery. PLoS One 2013; 8: e73397
15. Dawson K, Wakili R, Ordog B, Clauss S, Chen Y, Iwasaki Y, et al. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation 2013; 127: 1466-75, 1471e-1475e
16. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12: 1360-420
17. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Thromb Haemost 2012; 107: 1172-9
18. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of tumour-Associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141: 672-5
19. Fort A, Borel C, Migliavacca E, Antonarakis SE, Fish RJ, Neerman-Arbez M. Regulation of fibrinogen production by microRNAs. Blood 2010; 116: 2608-15
20. Kamath S, Lip GY. Fibrinogen: biochemistry, epidemiology and determinants. QJM 2003; 96: 711-29
21. Collet JP, Allali Y, Lesty C, Tanguy ML, Silvain J, Ankri A, et al. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 2006; 26: 2567-73
22. Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang F, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 2010; 122: 2378-87
23. Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai B, et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009; 83: 465-72
24. Girmatsion Z, Biliczki P, Bonauer A, Wimmer-Greinecker G, Scherer M, Moritz A, et al. Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Heart Rhythm 2009; 6: 1802-9
25. Liu Z, Zhou C, Liu Y, Wang S, Ye P, Miao X, et al. The expression levels of plasma micoRNAs in atrial fibrillation patients. PLoS One 2012; 7: e44906
26. Zhang Y, Dong D, Yang B. Atrial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation. Sci China Life Sci 2011; 54: 1097-102